Paper · 40402249
Cancer-associated fibroblast-derived SEMA3C facilitates colorectal cancer liver metastasis via NRP2-mediated MAPK activation.
Zhang Y and 16 others. Proc Natl Acad Sci U S A, 2025. Cited by 17 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cancer-associated fibroblast-derived SEMA3C facilitates colorectal cancer liver metastasis via NRP2-mediated MAPK activation. Papers, record 40402249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40402249
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cancer-associated fibroblast-derived SEMA3C facilitates colorectal cancer liver metastasis via NRP2-mediated MAPK activation.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| Liver Neoplasms | Major topic |
| Cancer-Associated Fibroblasts | Major topic |
| Neuropilin-2 | Major topic |
| Semaphorins | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Cell Line, Tumor | |
| MAP Kinase Signaling System | |
| Cell Proliferation | |
| Male |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34,992,217 | Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence. | Oncogene | 2022 | https://conductscience.org/library/papers/34992217 | PubMed |
| 2 | 26,457,759 | The consensus molecular subtypes of colorectal cancer. | Nat Med | 2015 | https://conductscience.org/library/papers/26457759 | PubMed |
| 3 | 34,019,806 | Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. | Cancer Cell | 2021 | https://conductscience.org/library/papers/34019806 | PubMed |
| 4 | 36,656,750 | Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma. | Neuro Oncol | 2023 | https://conductscience.org/library/papers/36656750 | PubMed |
| 5 | 33,659,878 | Interplay between tumor microenvironment and partial EMT as the driver of tumor progression. | iScience | 2021 | https://conductscience.org/library/papers/33659878 | PubMed |
| 6 | 31,740,819 | Fast, sensitive and accurate integration of single-cell data with Harmony. | Nat Methods | 2019 | https://conductscience.org/library/papers/31740819 | PubMed |
| 7 | 34,124,690 | Activation of p38α stress-activated protein kinase drives the formation of the pre-metastatic niche in the lungs. | Nat Cancer | 2020 | https://conductscience.org/library/papers/34124690 | PubMed |
| 8 | 24,925,914 | Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. | Science | 2014 | https://conductscience.org/library/papers/24925914 | PubMed |
| 9 | 36,239,989 | Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated SPP1+ Macrophages and Fibroblasts. | Clin Cancer Res | 2023 | https://conductscience.org/library/papers/36239989 | PubMed |
| 10 | 31,980,749 | A framework for advancing our understanding of cancer-associated fibroblasts. | Nat Rev Cancer | 2020 | https://conductscience.org/library/papers/31980749 | PubMed |
1 to 10 of 35
See all 35 referencesCited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,910,128 | FLNA Expression in Cancer-Associated Fibroblasts Is Associated with Immunosuppression and Tumor Progression in Colorectal Cancer. | J Cancer | 2026 | https://conductscience.org/library/papers/42910128 | PubMed |
| 42,880,979 | Neuro-associated SEMA3C+ tumour cells promote gastric cancer peritoneal metastasis via EBF2-FGF7-FGFR2-mediated tumour-endothelial crosstalk. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/42880979 | PubMed |
| 42,794,806 | Colitis-Associated Colorectal Cancer-STAT3 Inhibition as a Preventive Strategy. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794806 | PubMed |
| 42,688,481 | Pathway-based molecular subtyping identifies LAMP5 as an EMT-associated prognostic target in colorectal cancer. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42688481 | PubMed |
| 42,543,026 | Functional Role of ALKBH5 in Kidney Injury: Insights Into Mechanisms and Therapeutic Potential. | J Cell Biochem | 2026 | https://conductscience.org/library/papers/42543026 | PubMed |
| 42,530,712 | Colorectal cancer-derived exosomal ETS2 promotes macrophage M2 polarization by transcriptionally activating PRPF4. | Hum Cell | 2026 | https://conductscience.org/library/papers/42530712 | PubMed |
| 42,497,870 | A self-amplifying nerve-fibroblast circuit drives colorectal cancer progression. | Cancer Cell | 2026 | https://conductscience.org/library/papers/42497870 | PubMed |
| 42,333,245 | Multi-Omics Analysis Identifies Phosphoglucomutase 2 as a Potential Target to Alleviate Chemoradiotherapy Resistance in Cervical Cancer Cells. | Onco Targets Ther | 2026 | https://conductscience.org/library/papers/42333245 | PubMed |
| 42,304,476 | Integrative spatiotemporal transcriptomics identifies a liver metastasis-related initial cell population associated with the SEMA3A-NRP1 axis in pancreatic ductal adenocarcinoma. | J Transl Med | 2026 | https://conductscience.org/library/papers/42304476 | PubMed |
| 41,792,569 | Construction of a SEMA3 family-based model to predict prognosis and molecular subtypes in pancreatic ductal adenocarcinoma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41792569 | PubMed |
1 to 10 of 16
See all 16 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NRP2 | 8,828 | PubTator's text mining | https://conductscience.org/library/genes/8828 | NCBI Gene |
| SEMA3C | 10,512 | PubTator's text mining | https://conductscience.org/library/genes/10512 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40402249
GET https://conductscience.org/api/papers/v1/40402249/references?page=2